These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 30355737)

  • 61. Novel cell culture model for prevention of carcinogenic risk in familial adenomatous polyposis syndrome.
    Telang N; Katdare M
    Oncol Rep; 2009 Apr; 21(4):1017-21. PubMed ID: 19288003
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Tumor attenuation by combined heparan sulfate and polyamine depletion.
    Belting M; Borsig L; Fuster MM; Brown JR; Persson L; Fransson LA; Esko JD
    Proc Natl Acad Sci U S A; 2002 Jan; 99(1):371-6. PubMed ID: 11752393
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Selenium and difluoromethylornithine additively inhibit DMH-induced distal colon tumor formation in rats fed a fiber-free diet.
    McGarrity TJ; Peiffer LP
    Carcinogenesis; 1993 Nov; 14(11):2335-40. PubMed ID: 8242864
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Polyamine depletion stabilizes p53 resulting in inhibition of normal intestinal epithelial cell proliferation.
    Li L; Rao JN; Guo X; Liu L; Santora R; Bass BL; Wang JY
    Am J Physiol Cell Physiol; 2001 Sep; 281(3):C941-53. PubMed ID: 11502571
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Polyamine Depletion Strategies in Cancer: Remodeling the Tumor Immune Microenvironment to Enhance Anti-Tumor Responses.
    Chin A; Bieberich CJ; Stewart TM; Casero RA
    Med Sci (Basel); 2022 Jun; 10(2):. PubMed ID: 35736351
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Differential effects of polyamine homologues on the prevention of DL-alpha-difluoromethylornithine-mediated inhibition of malignant cell growth and normal immune response.
    Singh AB; Thomas TJ; Thomas T; Singh M; Mann RA
    Cancer Res; 1992 Apr; 52(7):1840-7. PubMed ID: 1551114
    [TBL] [Abstract][Full Text] [Related]  

  • 67. 2-Deoxy-D-glucose inhibits the antitumor effects of alpha-difluoromethylornithine on the growth of colon cancer in vivo.
    Saydjari R; Upp JR; Alexander RW; Barranco SC; Townsend CM; Thompson JC
    Invest New Drugs; 1989 Jul; 7(2-3):131-8. PubMed ID: 2507471
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Mebendazole and a non-steroidal anti-inflammatory combine to reduce tumor initiation in a colon cancer preclinical model.
    Williamson T; Bai RY; Staedtke V; Huso D; Riggins GJ
    Oncotarget; 2016 Oct; 7(42):68571-68584. PubMed ID: 27612418
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Increased survival of L1210 leukemic mice by prevention of the utilization of extracellular polyamines. Studies using a polyamine-uptake mutant, antibiotics and a polyamine-deficient diet.
    Ask A; Persson L; Heby O
    Cancer Lett; 1992 Sep; 66(1):29-34. PubMed ID: 1451093
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Triethylenetetramine modulates polyamine and energy metabolism and inhibits cancer cell proliferation.
    Hyvönen MT; Ucal S; Pasanen M; Peräniemi S; Weisell J; Khomutov M; Khomutov AR; Vepsäläinen J; Alhonen L; Keinänen TA
    Biochem J; 2016 May; 473(10):1433-41. PubMed ID: 27001865
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Urinary and erythrocyte polyamines during the evaluation of oral alpha-difluoromethylornithine in a phase I chemoprevention clinical trial.
    Pendyala L; Creaven PJ; Porter CW
    Cancer Epidemiol Biomarkers Prev; 1993; 2(3):235-41. PubMed ID: 8318876
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cytotoxic response of the relatively difluoromethylornithine-resistant human lung tumor cell line NCI H157 to the polyamine analogue N1,N8-bis(ethyl)spermidine.
    Casero RA; Go B; Theiss HW; Smith J; Baylin SB; Luk GD
    Cancer Res; 1987 Aug; 47(15):3964-7. PubMed ID: 3038303
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of alpha-difluoromethylornithine-induced polyamine depletion on the radiosensitivity of a human colon carcinoma cell line.
    Arundel CM; Nishioka K; Tofilon PJ
    Radiat Res; 1988 Jun; 114(3):634-40. PubMed ID: 3131831
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Combination therapy with 2-difluoromethylornithine and a polyamine transport inhibitor against murine squamous cell carcinoma.
    Chen Y; Weeks RS; Burns MR; Boorman DW; Klein-Szanto A; O'Brien TG
    Int J Cancer; 2006 May; 118(9):2344-9. PubMed ID: 16331620
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Preventive effects of NSAIDs, NO-NSAIDs, and NSAIDs plus difluoromethylornithine in a chemically induced urinary bladder cancer model.
    Nicastro HL; Grubbs CJ; Margaret Juliana M; Bode AM; Kim MS; Lu Y; You M; Milne GL; Boring D; Steele VE; Lubet RA
    Cancer Prev Res (Phila); 2014 Feb; 7(2):246-54. PubMed ID: 24346344
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Primary prevention: phytoprevention and chemoprevention of colorectal cancer.
    Turini ME; DuBois RN
    Hematol Oncol Clin North Am; 2002 Aug; 16(4):811-40. PubMed ID: 12418050
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Polyamines and the intestinal tract.
    Seiler N; Raul F
    Crit Rev Clin Lab Sci; 2007; 44(4):365-411. PubMed ID: 17558654
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and Progression.
    Evageliou NF; Haber M; Vu A; Laetsch TW; Murray J; Gamble LD; Cheng NC; Liu K; Reese M; Corrigan KA; Ziegler DS; Webber H; Hayes CS; Pawel B; Marshall GM; Zhao H; Gilmour SK; Norris MD; Hogarty MD
    Clin Cancer Res; 2016 Sep; 22(17):4391-404. PubMed ID: 27012811
    [TBL] [Abstract][Full Text] [Related]  

  • 79. CDK inhibitors induce mitochondria-mediated apoptosis through the activation of polyamine catabolic pathway in LNCaP, DU145 and PC3 prostate cancer cells.
    Arisan ED; Obakan P; Coker-Gurkan A; Calcabrini A; Agostinelli E; Unsal NP
    Curr Pharm Des; 2014; 20(2):180-8. PubMed ID: 23701543
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Influence of K-ras activation on the survival responses of Caco-2 cells to the chemopreventive agents sulindac and difluoromethylornithine.
    Lawson KR; Ignatenko NA; Piazza GA; Cui H; Gerner EW
    Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1155-62. PubMed ID: 11097222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.